Global X Aging Population ETFAGNG
AGNG
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more funds holding
Funds holding: 33 [Q4 2024] → 33 (+0) [Q1 2025]
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
4% less capital invested
Capital invested by funds: $28.2M [Q4 2024] → $27M (-$1.18M) [Q1 2025]
2.7% less ownership
Funds ownership: 48.87% [Q4 2024] → 46.17% (-2.7%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for AGNG.
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Neutral
Seeking Alpha
4 months ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Positive
InvestorPlace
1 year ago
The 3 Hottest Healthcare ETFs to Buy in 2024
Healthcare stocks started the year off very strongly as investors cheered the sector's advances. Among the sector's catalysts have been continued, strong enthusiasm for a new class of weight-loss drugs called GLP-1 and Nvidia's decision, disclosed earlier this month, to invest in a medical imaging company and a firm that uses artificial intelligence ( AI ) to speed up the drug discovery process.
Charts implemented using Lightweight Charts™